About Colin Goddard
Colin Goddard is a director at OS Therapies.
Colin Goddard reports to the SEC as a director or officer of 4 public companies, including Endocyte (ECYT), Human Genome Sciences (HGSI) and Osi Pharmaceuticals (OSIP).
Colin Goddard first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Colin Goddard in the role, so the role may have started earlier or lasted longer.
EI
Endocyte Inc.
Director
2013 – 2018 · Public company (ECYT)
HI
Human Genome Sciences Inc.
Director
2010 – 2012 · Public company (HGSI)
OI
Osi Pharmaceuticals Inc.
Chief Executive Officer and director
2006 – 2010 · Public company (OSIP)
Key Colleagues at Startups
The people Colin Goddard works with at each company, as listed on that company's latest Form D.
OS Therapies Inc · Form D, Dec 14, 2023
PR
Paul Romness
Founder, President, Chief Executive Officer and Director
TS
Theodore Search
Director
JB
Joacim Borg
Director
CA
Christopher Acevedo
Chief Financial Officer
RP
Robert Petit
Chief Medical Officer and Chief Scientific Officer
JC
John Ciccio
Director